NewSquare Capital’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

NewSquare Capital’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2	Closed	–	–	402
2021 Q2	$0	Hold	2	–	–	﹤0.01%	381
2021 Q1	$0	Hold	2	–	–	﹤0.01%	380
2020 Q4	$0	Hold	2	–	–	﹤0.01%	403
2020 Q3	$0	Hold	2	–	–	﹤0.01%	423
2020 Q2	$0	Sell	2 -72	-97%	-$2.81K	﹤0.01%	468
2020 Q1	$0	Buy	+74	New	+$10.5K	﹤0.01%	418

Other funds holding NVIV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ICM

IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

NewSquare Capital's NVIV Position: Q3 2021 in Review

NewSquare Capital sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q3 2021, closing a stake of 2 shares.

NewSquare Capital first reported a position in NVIV in Q1 2020 and held it in 6 quarters. The position peaked at $0 in Q2 2021. 16 funds tracked by Wall St. Rank hold NVIV as of Q3 2021.

NewSquare Capital reported no remaining InVivo Therapeutics Holdings Corp position as of Q3 2021 after selling out during the quarter.
NewSquare Capital sold 2 InVivo Therapeutics Holdings Corp shares in Q3 2021.
NewSquare Capital first reported a position in InVivo Therapeutics Holdings Corp in Q1 2020 and held it in 6 quarters.
NewSquare Capital's InVivo Therapeutics Holdings Corp position peaked at $0 in Q2 2021.
16 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2021.

Based on NewSquare Capital's 13F filing for Q3 2021, filed 8 Nov 2021.